Efficacy of GLP-1 analog to achieve metabolic control and correction of body weight in patients with type 2 diabetes mellitus

Efficacy of GLP-1 analog to achieve metabolic control and correction of body weight in patients with type 2 diabetes mellitus

Obesity associated with the enhanced risk of cardiovascular disorders plays a key role in the evolvement and progression of type 2 diabetes mellitus (DM2). Incretin mimetics are the sole class of hypoglycemic agents that not only effectively correct hyperglycemia but also reduce body weight. Exenati...

Full description

Saved in:
Bibliographic Details
Main Authors: T. V. Saprina, T. K. Gudkova, V. A. Stolyarova, S. Yu. Martynova, N. G. Dudarkova, T. G. Yaroshevskaya, Yu. A. Kabirova, O. A. Pavlenko, I. N. Vorozhtsova
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2011-12-01
Series:Бюллетень сибирской медицины
Subjects:
type 2 diabetes mellitus
obesity
incretin mimetics
exenatide
byetta
Online Access:https://bulletin.ssmu.ru/jour/article/view/1511
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bulletin.ssmu.ru/jour/article/view/1511

Similar Items